2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Mama ≥98.0% (HPLC)

Fa'amatalaga Puupuu:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

Fa'aaliga: Pa'epa'e Pa'epa'e po'o le Pa'epa'e Pa'epa'e

Mama: ≥98.0% (HPLC)

Intermediate of API (CAS: 842133-18-0) i le togafitiga o le ituaiga 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com

Auina imeli ia matou

Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Manufacturer Supply Fa'atatau Fa'atatau:
4-Fluorophenylboronic Acid CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0

Meatotino tau vailaau:

Igoa Vailaau	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Numera CAS	1030825-20-7
CAT Numera	RF-PI234
Tulaga Fa'asoa	I Fa'atauga, Oloa Fua e O'o i le selau Kilograms
Fuafua mole	C18H14BrFS
Molecular Weight	361.27
Lisi Lisi	103℃
Malosi	1.388
Fa'ailoga	Ruifu Chemical

Fa'amatalaga:

Aitema	Fa'amatalaga
Fa'aaliga	Pa'epa'e po'o le Pa'epa'e Pa'epa'e
Mama / Suʻesuʻega Metotia	≥98.0% (HPLC)
Ma'imau ile Fa'amago	≤1.00%
Toega ile mu	≤0.50%
Metala mamafa	≤20ppm
Tulaga Su'ega	Enterprise Standard
Fa'aoga	Intermediate of API (CAS: 842133-18-0)

Paket & Teuina:

afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu

Tulaga lelei:

FAQ:

Talosaga:

Shanghai Ruifu Chemical Co., Ltd. o le taʻutaʻua taʻutaʻua ma le tuʻuina atu o le 2-(5-Bromo-2-Methylbenzyl) -5- (4-Fluorophenyl) thiophene (CAS: 1030825-20-7) faʻatasi ai ma le maualuga.Eose vaeluaga masani i le tuufaatasia o API (CAS: 461432-26-8).API (CAS: 461432-26-8) o se vailaʻau faʻamaʻi faʻamaʻi fou na fausia faʻatasi e Bristol-Myers Squibb ma AstraZeneca, faʻamaonia e le European Medicines Agency (EMA) i le aso 12 o Novema, 2012. O le faʻatagaina muamua foʻi o le SGLT2 inhibitor mo le togafitiga o le ma'isuka ituaiga II, o se filifiliga taua i le togafitiga o le ma'i suka, ma e fa'aaogaina e fa'aleleia ai le pulea o le glycemic e fa'aopoopo i mea'ai ma fa'amalositino mo tagata matutua e maua i le ma'isuka ituaiga II.